SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
SEC Accession No. 0001193125-14-415228
Filing Date
2014-11-17
Accepted
2014-11-17 16:43:53
Documents
1
Effectiveness Date
2014-11-17

Document Format Files

Seq Description Document Type Size
1 S-8 POS d821965ds8pos.htm S-8 POS 19426
  Complete submission text file 0001193125-14-415228.txt   20453
Mailing Address 200 SOUTH WACKER DRIVE SUITE 2550 CHICAGO IL 60606
Business Address 200 SOUTH WACKER DRIVE SUITE 2550 CHICAGO IL 60606 312-219-7000
Durata Therapeutics, Inc. (Filer) CIK: 0001544116 (see all company filings)

IRS No.: 871247903 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 POS | Act: 33 | File No.: 333-194729 | Film No.: 141228373
SIC: 2834 Pharmaceutical Preparations